Treatment of Patients with Chronic Myeloid Leukemia During Pregnancy According to Scheme Considering the Leukemic Burden and Term of Pregnancy (the LRT Scheme)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2018)
摘要
The risk-benefits evaluation in patients with CML during pregnancy is a challenge.
更多查看译文
关键词
chronic myeloid leukemia,CML,pregnancy,tyrosine kinase inhibitor,imatinib,nilotinib,dasatinib
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要